L'immunothérapie passe la quatrième avec les CAR T-cells : IMMUNO-ONCOLOGIE: Le combat biotech contre le cancerSIMON, Mathieu; SMITH, Julianne; VERNET, Agnès et al.Biofutur (Puteaux). 2014, Vol 352, pp 44-47, issn 0294-3506, 4 p.Article

Traitement médicamenteux du SIDA = Aids treatmentCOULAUD, J.-P.Gazette médicale de France (1969). 1989, Vol 96, Num 15, issn 0016-5557, 49Article

Adjunct Immunotherapies for TuberculosisUHLIN, Michael; ANDERSSON, Jan; ZUMLA, Alimuddin et al.The Journal of infectious diseases. 2012, Vol 205, issn 0022-1899, S325-S334, SUP2Article

Immunoglobulin therapyFINLAYSON, J. S; TANKERSLEY, D. L.Lancet (British edition). 1991, Vol 338, Num 8771, pp 893-894, issn 0140-6736Article

Immunotherapy with reptidesLARCHE, M.European annals of allergy and clinical immunology. 2006, Vol 38, Num 7, pp 240-243, issn 1764-1489, 4 p.Conference Paper

New approaches to the immunotherapy of cancerTOPALIAN, S. L; ROSENBERG, S. A.Natural immunity and cell growth regulation. 1988, Vol 7, Num 3, issn 0254-7600, 169Article

L'immunothérapie homoépathique = Immunotherapy in homeopathyJENAER, M; MARICHAL, B.L' Homéopathie française (Paris. 1912). 1988, Vol 76, Num 5, pp 281-299, issn 0018-4225Article

Herausforderungen bei der biotechnologischen Herstellung von monoklonalen Antikörpern : Therapie mit monoklonalen Antikörpern: aktueller Stand und Perspektiven = Therapy with monoclonal antibodies: Current status and perspectivesKLEIN, Andreas.Arzneimittel-Forschung. 2005, Vol 55, Num 11, issn 0004-4172, p. 696Conference Paper

Therapeutic vaccines : a solution to the prevention problem?DAWSON, Angus.Vaccine. 2005, Vol 23, Num 17-18, pp 2363-2366, issn 0264-410X, 4 p.Conference Paper

Environmental controls and immunotherapy in the treatment of chronic asthmaADINOFF, A. D.The Journal of asthma. 1990, Vol 27, Num 5, pp 277-289, issn 0277-0903, 13 p.Conference Paper

Oral immunotherapy of chronic bronchitis: a double-blind placebo-controlled multicentre studyCVORISCEC, B; USTAR, M; PARDON, R et al.Respiration (Basel). 1989, Vol 55, Num 3, pp 129-135, issn 0025-7931Article

Suppression of the late cutaneous response by immunotherapyFLING, J. A; RUFF, M. E; PARKER, W. A et al.Journal of allergy and clinical immunology. 1989, Vol 83, Num 1, pp 101-109, issn 0091-6749Article

Adjuvant specific active lung cancer immunotherapy trials: tumor-associated antigensHOLLINSHEAD, A; STEWART, T. H. M; TAKITA, H et al.Cancer. 1987, Vol 60, Num 6, pp 1249-1262, issn 0008-543XArticle

Monoklonale Antikörper bei Lymphomen : Chemo-immunotherapy - the Role of Monoclonal Antibodies for the Treatment of Chronic Lymphocytic Leukemia (CLL) : Therapie mit monoklonalen Antikörpern: aktueller Stand und Perspektiven = Therapy with monoclonal antibodies: Current status and perspectivesHALLEK, Michael; WENDTNER, Clemens-Martin; EMMERICH, Bertold et al.Arzneimittel-Forschung. 2005, Vol 55, Num 11, pp 704-705, issn 0004-4172, 2 p.Conference Paper

Radioaktiv markierte monoklonale Antikörper bei Non-Hodgkin-Lymphom : Therapie mit monoklonalen Antikörpern: aktueller Stand und Perspektiven = Therapy with monoclonal antibodies: Current status and perspectivesKALMUS, Joachim.Arzneimittel-Forschung. 2005, Vol 55, Num 11, pp 706-707, issn 0004-4172, 2 p.Conference Paper

La désensibilisation est-elle une thérapeutique dangereuse? = Is desensitization a dangerous therapy?HARDEL, P. J; GONTIER, B.Médecine et armées. 1989, Vol 17, Num 6, pp 483-487, issn 0300-4937, 5 p.Article

A trial of adjuvant immunotherapy for bronchial carcinoma with irradiated autochthonous tumour cellsPRICE EVANS, D. A; ROBERTS, H. L; HEWITT, S et al.International journal of immunotherapy. 1987, Vol 3, Num 4, pp 293-300, issn 0255-9625Article

Antitumor actions of interferons: direct, indirect, and synergy with other treatment modalitiesTYRING, S. K.International journal of dermatology. 1987, Vol 26, Num 9, pp 549-556, issn 0011-9059Article

Immunotherapy of lung cancer: a randomized clinical trial of OK-432 immunotherapy and a review of the literature on nonspecific immunotherapyWATANABE, Y; IWA, T.International journal of immunotherapy. 1986, Vol 2, Num 1, pp 51-67, issn 0255-9625Article

Antikörpertherapien beim Ovarialkarzinom : Therapie mit monoklonalen Antikörpern: aktueller Stand und Perspektiven = Therapy with monoclonal antibodies: Current status and perspectivesKIMMIG, Rainer; WIMBERGER, Pauline.Arzneimittel-Forschung. 2005, Vol 55, Num 11, pp 711-712, issn 0004-4172, 2 p.Conference Paper

L'avènement du traitement biologique des cancersLA LETTRE DE LA PREVENTION. 1989, Num 160, pp 1-3Article

Preparation and therapeutic potential of antibody-anticancer drug immunoconjugatesSINKULE, J. A.Lung biology in health and disease. 1988, Vol 37, pp 297-327, issn 0362-3181Article

Quel avenir pour l'immunothérapie ?DUTAU, G.Revue française d'allergologie (Amsterdam. Print). 2011, Vol 51, pp 23-24, issn 1877-0312, 2 p., HS2Article

Monoklonale Antikörpertherapie bei rheumatoider Arthritis : Therapie mit monoklonalen Antikörpern: aktueller Stand und Perspektiven = Therapy with monoclonal antibodies: Current status and perspectivesKALDEN, Joachim Robert.Arzneimittel-Forschung. 2005, Vol 55, Num 11, issn 0004-4172, p. 700Conference Paper

Monoklonale Antikörper bei Psoriasis : Therapie mit monoklonalen Antikörpern: aktueller Stand und Perspektiven = Therapy with monoclonal antibodies: Current status and perspectivesBOEHNCKE, Wolf-Henning.Arzneimittel-Forschung. 2005, Vol 55, Num 11, pp 701-702, issn 0004-4172, 2 p.Conference Paper